|
|||||
|
|
Key Points to Consider When Evaluating Andexxa for Formulary Addition |
|
| Authors: | Peled Harry Dau Nhu Quyen Lau Helen |
| Institution: | 1.Pharmacy and Therapeutics Committee Chair, St. Jude Medical Center, 101 Val Mesa Drive, Fullerton, CA, 92835, USA ;2.Department of Pharmacy Practice, Marshall B. Ketchum University College of Pharmacy, Fullerton, CA, USA ;3.Southern California Regional Clinical Quality and Risk Manager, Providence St. Joseph Health, Irvine, CA, USA ; |
| Abstract: | Neurocritical Care - |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |